{"title":"[Pain: the story of a prejudice ?]","authors":"Philippe Charlier","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 2","pages":"149-150"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Innovations in surgical oncology practice].","authors":"Judicaël Hotton","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>INNOVATIONS IN SURGICAL ONCOLOGY PRACTICE. Oncology surgery is evolving with the times. It is used to treat the most common, and serious cancers, such as lung, gynecological, prostate, and colon. One of the major advances is robotic surgery, which optimizes the minimally invasive approach to enable increasingly complex procedures to be carried out, while reducing blood loss, complications and post-operative pain, and speeding recovery and return home. This technology also offers real-time endoscopic imaging, potentially coupled with fluorescence or three-dimensional modelling for improved intra-operative assessment. Accelerated recovery after surgery aims to improve post-operative recovery and patient well-being, while reducing complications and hospital stays. Finally, surgical simulation uses equipment, virtual reality or standardized patients to teach and rehearse diagnostic and therapeutic procedures, thus improving the training of healthcare professionals.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 2","pages":"164-167"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[The definition of clinical obesity is changing!]","authors":"Martine Laville, Karine Clément, François Pattou","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 2","pages":"119"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Therapeutic classes in medical oncology].","authors":"Diana Bello Roufai","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>THERAPEUTIC CLASSES IN MEDICAL ONCOLOGY. Medical oncology is constantly evolving, utilizing various systemic therapies to treat cancer at different stages. Chemotherapy, antibody-drug conjugates, immunotherapy, targeted therapies, and hormone therapy represent the main current strategies. The evolution of treatments, particularly with CAR-T cells, aims to improve patient survival while reducing side effects. Emphasis is placed on precision medicine and improving patients' quality of life, with supportive care integrated into innovative treatments.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 2","pages":"168-171"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Impacts of endocrine disruptors on the placenta].","authors":"Florence Joly","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>IMPACTS OF ENDOCRINE DISRUPTORS ON THE PLACENTA. The placenta is a transitional organ that plays a major role during pregnancy, providing the vital functions required for the development of the fetus. However, its development and functions are still poorly understood. Exposure of pregnant women to chemical substances such as endocrine disruptors (ED) significantly impacts the placental development and disrupts its functioning. The impact of EDs on the placenta is primarily reflected in the increased occurrence of pregnancy complications, negatively influences the development of the fetus and contributes to the onset of chronic pathologies in childhood (asthma, obesity, IHD, ADHD, etc.) and adulthood (hormone-dependent cancers, diabetes, etc.). Recent data from studies carried out in vitro, in vivo, in experimental models or through epidemiological studies have enabled to better characterize the molecular pathways impacted, the physiological processes altered, and the consequences of exposure to EDs on the placenta.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 2","pages":"187-195"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[New treatments for cutaneous lupus].","authors":"François Chasset","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>NEW TREATMENTS FOR CUTANEOUS LUPUS. Cutaneous lupus may present as an isolated skin disease, or may be associated with systemic lupus, of which it is one of the most frequent manifestations. The management of this disease is poorly codified, and treatment depends on the severity of the disease, whether or not it is associated with systemic lupus, and many other factors. Synthetic antimalarials, in particular hydroxychloroquine, are the cornerstone of treatment. In recent years, several molecules have shown results that are both highly promising and disappointing. A major new development is the granting of European marketing authorization for anifrolumab in systemic lupus in 2022, which seems to be producing particularly interesting results in skin involvement.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 2","pages":"123-130"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}